{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T21:34:08Z","timestamp":1774301648685,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hengyu Li","award":["82473010"],"award-info":[{"award-number":["82473010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-25299-4","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T11:55:17Z","timestamp":1763726117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated analysis reveals survival-related genes promoting cholangiocarcinoma progression via G2\/M cell cycle, with validation of cyclin B1 in tumor proliferation"],"prefix":"10.1038","volume":"15","author":[{"given":"Qingliang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianglin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weichen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"25299_CR1","unstructured":"Banales, J. M. et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastro Hepat 17 557 (2020). (2020)."},{"key":"25299_CR2","doi-asserted-by":"publisher","first-page":"217540","DOI":"10.1016\/j.canlet.2025.217540","volume":"614","author":"X Cui","year":"2025","unstructured":"Cui, X., Huang, T., Jiang, T. & Wang, H. Current status and prospects of targeted therapy for cholangiocarcinoma based on molecular characteristics. Cancer Lett. 614, 217540 (2025).","journal-title":"Cancer Lett."},{"key":"25299_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13046-024-03210-9","volume":"43","author":"S Mancarella","year":"2024","unstructured":"Mancarella, S. et al. Targeting cancer-associated fibroblasts\/tumor cells cross-talk inhibits intrahepatic cholangiocarcinoma progression via cell-cycle arrest. J. Exp. Clin. Canc Res. 43, 286 (2024).","journal-title":"J. Exp. Clin. Canc Res."},{"key":"25299_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s43018-024-00893-z","volume":"6","author":"JJ Asciolla","year":"2025","unstructured":"Asciolla, J. J., Wu, X., Adamopoulos, C., Gavathiotis, E. & Poulikakos, P. I. Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer. Nat. Cancer 6, 24 (2025).","journal-title":"Nat. Cancer"},{"key":"25299_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41568-021-00411-8","volume":"22","author":"SJ Vervoort","year":"2022","unstructured":"Vervoort, S. J. et al. Targeting transcription cycles in cancer. Nat. Rev. Cancer 22, 5 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"25299_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2017.05.009","volume":"32","author":"J Chaisaingmongkol","year":"2017","unstructured":"Chaisaingmongkol, J. et al. Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma. Cancer Cell. 32, 57 (2017).","journal-title":"Cancer Cell."},{"key":"25299_CR7","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","volume":"142","author":"JB Andersen","year":"2012","unstructured":"Andersen, J. B. et al. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology 142, 1021 (2012).","journal-title":"Gastroenterology"},{"key":"25299_CR8","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","volume":"73","author":"M Zhang","year":"2020","unstructured":"Zhang, M. et al. Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma. J. Hepatol. 73, 1118 (2020).","journal-title":"J. Hepatol."},{"key":"25299_CR9","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.jhep.2022.05.043","volume":"77","author":"G Alvisi","year":"2022","unstructured":"Alvisi, G. et al. Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target. J. Hepatol. 77, 1359 (2022).","journal-title":"J. Hepatol."},{"key":"25299_CR10","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00428-024-03922-5","volume":"485","author":"G Lubuela","year":"2024","unstructured":"Lubuela, G. et al. Prognostic impact of the tumour microenvironment in intrahepatic cholangiocarcinoma: identification of a peritumoural fibro-immune interface. Virchows Arch. 485, 901 (2024).","journal-title":"Virchows Arch."},{"key":"25299_CR11","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"25299_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham, H. ggplot2: Elegant graphics for data analysis (Springer, 2016)."},{"key":"25299_CR13","unstructured":"Kolde, R. pheatmap: Pretty Heatmaps (Version 1.0.12) [R package] (2019)."},{"key":"25299_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.18637\/jss.v046.i11","volume":"46","author":"P Langfelder","year":"2012","unstructured":"Langfelder, P. & Horvath, S. Fast R functions for robust correlations and hierarchical clustering. J. Stat. Softw. 46, 46 (2012).","journal-title":"J. Stat. Softw."},{"key":"25299_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 9, 559 (2008).","journal-title":"BMC Bioinform."},{"key":"25299_CR16","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","volume":"19","author":"S Xu","year":"2024","unstructured":"Xu, S. et al. Using clusterprofiler to characterize multiomics data. Nat. Protoc. 19, 3292 (2024).","journal-title":"Nat. Protoc."},{"key":"25299_CR17","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672 (2025).","journal-title":"Nucleic Acids Res."},{"key":"25299_CR18","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"1947","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947 (1947).","journal-title":"Protein Sci."},{"key":"25299_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"25299_CR20","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinform. 12, 77 (2011).","journal-title":"BMC Bioinform."},{"key":"25299_CR21","doi-asserted-by":"publisher","first-page":"107064","DOI":"10.1016\/j.ejso.2023.107064","volume":"51","author":"M Qurashi","year":"2025","unstructured":"Qurashi, M., Vithayathil, M. & Khan, S. A. Epidemiology of cholangiocarcinoma. EJSO-Eur J. Surg. Onc 51, 107064 (2025).","journal-title":"EJSO-Eur J. Surg. Onc"},{"key":"25299_CR22","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1038\/s41467-025-57996-z","volume":"16","author":"D Cai","year":"2025","unstructured":"Cai, D. et al. Foxk1 and Foxk2 promote cardiomyocyte proliferation and heart regeneration. Nat. Commun. 16, 2877 (2025).","journal-title":"Nat. Commun."},{"key":"25299_CR23","first-page":"e925289","volume":"CDK1","author":"Y Zou","year":"2020","unstructured":"Zou, Y. et al. CCNB1, and CCNB2 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma. Med. Sci. Monit. CDK1, e925289 (2020).","journal-title":"Med. Sci. Monit."},{"key":"25299_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3892\/br.2020.1346","volume":"13","author":"Q Zhao","year":"2020","unstructured":"Zhao, Q. et al. Bioinformatics analysis shows that TOP2A functions as a key candidate gene in the progression of cervical cancer. Biomed. Rep. 13, 21 (2020).","journal-title":"Biomed. Rep."},{"key":"25299_CR25","doi-asserted-by":"publisher","first-page":"1220780199","DOI":"10.1177\/0300060520980647","volume":"49","author":"Z Xing","year":"2021","unstructured":"Xing, Z. et al. Expression and prognostic value of CDK1, CCNA2, and CCNB1 gene clusters in human breast cancer. J. Int. Med. Res. 49, 1220780199 (2021).","journal-title":"J. Int. Med. Res."},{"key":"25299_CR26","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2147\/CMAR.S478426","volume":"16","author":"J Li","year":"2024","unstructured":"Li, J., Liu, Q., Zhang, T. & Du, Q. Bioinformatics analysis reveals CDK1 and DLGAP5 as key modulators of tumor immune cell infiltration in hepatocellular carcinoma. Cancer Manag Res. 16, 1597 (2024).","journal-title":"Cancer Manag Res."},{"key":"25299_CR27","doi-asserted-by":"crossref","unstructured":"Di Sotto, A. et al. Modulation of STAT3 signaling, cell redox defenses and cell cycle checkpoints by \u03b2-caryophyllene in cholangiocarcinoma cells: Possible mechanisms accounting for doxorubicin chemosensitization and chemoprevention. Cells-Basel 9 (2020).","DOI":"10.3390\/cells9040858"},{"key":"25299_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/nu15143090","volume":"15","author":"T Lomphithak","year":"2023","unstructured":"Lomphithak, T., Jaikla, P., Sae-Fung, A., Sonkaew, S. & Jitkaew, S. Natural flavonoids quercetin and kaempferol targeting G2\/M cell cycle-related genes and synergize with smac mimetic LCL-161 to induce necroptosis in cholangiocarcinoma cells. Nutrients 15, 85 (2023).","journal-title":"Nutrients"},{"key":"25299_CR29","doi-asserted-by":"publisher","first-page":"e14374","DOI":"10.1111\/jfbc.14374","volume":"46","author":"Y Ren","year":"2022","unstructured":"Ren, Y. et al. Condensed tannins from Ulmus pumila L. leaves induce G2\/M phase arrest and apoptosis via caspase-cascade activation in TFK-1 cholangiocarcinoma cells. J. Food Biochem. 46, e14374 (2022).","journal-title":"J. Food Biochem."},{"key":"25299_CR30","doi-asserted-by":"crossref","unstructured":"Malacrida, A., Cavaletti, G. & Miloso, M. Rigosertib and cholangiocarcinoma: A cell cycle affair. Int J. Mol. Sci 23 (2021).","DOI":"10.3390\/ijms23010213"},{"key":"25299_CR31","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10495-017-1422-y","volume":"22","author":"S Thongsom","year":"2017","unstructured":"Thongsom, S., Suginta, W., Lee, K. J., Choe, H. & Talabnin, C. Piperlongumine induces G2\/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway. Apoptosis 22, 1473 (2017).","journal-title":"Apoptosis"},{"key":"25299_CR32","doi-asserted-by":"publisher","first-page":"154678","DOI":"10.1016\/j.prp.2023.154678","volume":"248","author":"H Riantana","year":"2023","unstructured":"Riantana, H. et al. BI6727 and GSK461364A, potent PLK1 inhibitors induce G2\/M arrest and apoptosis against cholangiocarcinoma cell lines. Pathol. Res. Pract. 248, 154678 (2023).","journal-title":"Pathol. Res. Pract."},{"key":"25299_CR33","doi-asserted-by":"publisher","first-page":"9093","DOI":"10.2147\/OTT.S226261","volume":"12","author":"XM Mao","year":"2019","unstructured":"Mao, X. M. et al. Diosgenin suppresses cholangiocarcinoma cells via inducing cell cycle arrest and Mitochondria-Mediated apoptosis. Oncotargets Ther. 12, 9093 (2019).","journal-title":"Oncotargets Ther."},{"key":"25299_CR34","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.4161\/cc.21105","volume":"11","author":"S Yamanaka","year":"2012","unstructured":"Yamanaka, S. et al. Coordinated effects of microRNA-494 induce G\u2082\/M arrest in human cholangiocarcinoma. Cell. Cycle 11, 2729 (2012).","journal-title":"Cell. Cycle"},{"key":"25299_CR35","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.humpath.2006.12.014","volume":"38","author":"Y Kuroda","year":"2007","unstructured":"Kuroda, Y. et al. 14-3-3sigma negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma. Hum. Pathol. 38, 1014 (2007).","journal-title":"Hum. Pathol."},{"key":"25299_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/molecules28217342","volume":"28","author":"T Rattanaburee","year":"2023","unstructured":"Rattanaburee, T., Chompunud, N. A. C., Thongpanchang, T., Tipmanee, V. & Graidist, P. Trans-(\u00b1)-TTPG-B attenuates cell cycle progression and inhibits cell proliferation on cholangiocarcinoma cells. Molecules 28, 96 (2023).","journal-title":"Molecules"},{"key":"25299_CR37","doi-asserted-by":"publisher","first-page":"586","DOI":"10.21037\/atm-22-1112","volume":"10","author":"H Liu","year":"2022","unstructured":"Liu, H., Zhou, Q., Xu, X., Du, Y. & Wu, J. ASPM and TROAP gene expression as potential malignant tumor markers. Ann. Transl Med. 10, 586 (2022).","journal-title":"Ann. Transl Med."},{"key":"25299_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/CAD.0000000000001563","volume":"35","author":"S Wei","year":"2024","unstructured":"Wei, S. et al. Silencing of KIF2C enhances the sensitivity of hepatocellular carcinoma cells to cisplatin through regulating the PI3K\/AKT\/MAPK signaling pathway. Anti-Cancer Drug 35, 237 (2024).","journal-title":"Anti-Cancer Drug"},{"key":"25299_CR39","doi-asserted-by":"publisher","first-page":"155714","DOI":"10.1016\/j.phymed.2024.155714","volume":"129","author":"Y Zou","year":"2024","unstructured":"Zou, Y. et al. Muscone restores Anoikis sensitivity in TMZ-resistant glioblastoma cells by suppressing TOP2A via the EGFR\/Integrin \u03b21\/FAK signaling pathway. Phytomedicine 129, 155714 (2024).","journal-title":"Phytomedicine"},{"key":"25299_CR40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41419-025-07587-z","volume":"16","author":"E Cakiroglu","year":"2025","unstructured":"Cakiroglu, E., Eris, S., Oz, O., Karak\u00fclah, G. & Senturk, S. Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma. Cell. Death Dis. 16, 241 (2025).","journal-title":"Cell. Death Dis."},{"key":"25299_CR41","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3892\/etm.2021.10680","volume":"22","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Knockdown of DLGAP5 suppresses cell proliferation, induces G(2)\/M phase arrest and apoptosis in ovarian cancer. Exp. Ther. Med. 22, 1245 (2021).","journal-title":"Exp. Ther. Med."},{"key":"25299_CR42","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10549-022-06801-2","volume":"198","author":"AI Aljohani","year":"2023","unstructured":"Aljohani, A. I., Toss, M. S., Green, A. R. & Rakha, E. A. The clinical significance of Cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development. Breast Cancer Res. Tr. 198, 423 (2023).","journal-title":"Breast Cancer Res. Tr."},{"key":"25299_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41698-025-00875-z","volume":"9","author":"P Ding","year":"2025","unstructured":"Ding, P. et al. Non-invasive liquid biopsy based on transcriptomic profiling for early diagnosis of occult peritoneal metastases in locally advanced gastric cancer. NPJ. Precis Oncol. 9, 109 (2025).","journal-title":"NPJ. Precis Oncol."},{"key":"25299_CR44","doi-asserted-by":"publisher","first-page":"1106175","DOI":"10.3389\/fendo.2022.1106175","volume":"13","author":"X Chen","year":"2022","unstructured":"Chen, X. et al. CCNB1 and AURKA are critical genes for prostate cancer progression and castration-resistant prostate cancer resistant to vinblastine. Front. Endocrinol. 13, 1106175 (2022).","journal-title":"Front. Endocrinol."},{"key":"25299_CR45","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41419-021-03973-5","volume":"12","author":"P Xia","year":"2021","unstructured":"Xia, P. et al. MYC-targeted WDR4 promotes proliferation, metastasis, and Sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma. Cell. Death Dis. 12, 691 (2021).","journal-title":"Cell. Death Dis."},{"key":"25299_CR46","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/0008-5472.CAN-24-1173","volume":"85","author":"J Nie","year":"2025","unstructured":"Nie, J. et al. Mapping of the T-cell landscape of biliary tract cancer unravels anatomic subtype-specific heterogeneity. Cancer Res. 85, 704 (2025).","journal-title":"Cancer Res."},{"key":"25299_CR47","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.7150\/thno.56539","volume":"11","author":"J Lin","year":"2021","unstructured":"Lin, J. et al. Mutational spectrum and precision oncology for biliary tract carcinoma. Theranostics 11, 4585 (2021).","journal-title":"Theranostics"},{"key":"25299_CR48","first-page":"20","volume":"10","author":"A Konstantinos","year":"2024","unstructured":"Konstantinos, A. et al. Shedding light on the role of LAG-3 in hepatocellular carcinoma: Unraveling immunomodulatory pathways. Hepatoma Res. 10, 20 (2024).","journal-title":"Hepatoma Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25299-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25299-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25299-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T13:04:48Z","timestamp":1763730288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25299-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25299"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25299-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41352"}}